Protein Equalizer Technology : the quest for a "democratic proteome".
about
Sample preparation techniques for the untargeted LC-MS-based discovery of peptides in complex biological matricesApplication of gel-based proteomic technique in female reproductive investigationsOpportunities and limitations of SELDI-TOF-MS in biomedical research: practical advicesQuantitative mass spectrometry analysis using PAcIFIC for the identification of plasma diagnostic biomarkers for abdominal aortic aneurysmDifferential denaturation of serum proteome reveals a significant amount of hidden information in complex mixtures of proteinsSolid-phase extraction strategies to surmount body fluid sample complexity in high-throughput mass spectrometry-based proteomicsAsymmetric proteome equalization of the skeletal muscle proteome using a combinatorial hexapeptide libraryQuantitative matrix-assisted laser desorption/ionization mass spectrometryQuantitative iTRAQ-Based Proteomic Identification of Candidate Biomarkers for Diabetic Nephropathy in Plasma of Type 1 Diabetic PatientsQuantitative proteomics of complex mixtures.Sherlock Holmes and the proteome--a detective story.Biomarker discovery in infectious diseases using SELDI.Proteomic analysis in cardiovascular diseases.Extensive analysis of the cytoplasmic proteome of human erythrocytes using the peptide ligand library technology and advanced mass spectrometry.A proteomic approach for plasma biomarker discovery with iTRAQ labelling and OFFGEL fractionation.Challenges for biomarker discovery in body fluids using SELDI-TOF-MS.In-depth exploration of cerebrospinal fluid by combining peptide ligand library treatment and label-free protein quantification.The proteome buccaneers: how to unearth your treasure chest via combinatorial peptide ligand libraries.Jeffamine derivatized TentaGel beads and poly(dimethylsiloxane) microbead cassettes for ultrahigh-throughput in situ releasable solution-phase cell-based screening of one-bead-one-compound combinatorial small molecule librariesProteomic technologies for the discovery of type 1 diabetes biomarkersImprovement of 2D-PAGE resolution of human, porcine and equine follicular fluid by means of hexapeptide ligand library.New pre-analytical approach for the deep proteome analysis of sera from pancreatitis and pancreas cancer patients.Hexapeptide libraries for enhanced protein PTM identification and relative abundance profiling in whole human saliva.Cardiovascular proteomics: translational studies to develop novel biomarkers in heart failure and left ventricular remodeling.Reduction of protein concentration range difference followed by multicolumn fractionation prior to 2-DE and LC-MS/MS profiling of serum proteins.Proteomic analysis of plasma derived from platelet buffy coats during storage at room temperature. An application of ProteoMiner™ technology.Highlights on the capacities of "Gel-based" proteomics.Combinatorial peptide ligand library treatment followed by a dual-enzyme, dual-activation approach on a nanoflow liquid chromatography/orbitrap/electron transfer dissociation system for comprehensive analysis of swine plasma proteome.Optimizing protein recovery yield from serum samples treated with beads technology.Improvements in proteomic metrics of low abundance proteins through proteome equalization using ProteoMiner prior to MudPIT.Enriched sera protein profiling for detection of non-small cell lung cancer biomarkers.Combined use of a solid-phase hexapeptide ligand library with liquid chromatography and two-dimensional difference gel electrophoresis for intact plasma proteomics.Proteomic analysis of human plasma in chronic rheumatic mitral stenosis reveals proteins involved in the complement and coagulation cascadeIdentification of genital tract markers in the human seminal plasma using an integrative genomics approach.Human serum proteome analysis: new source of markers in metabolic disorders.Bioanalysis: Heri, hodie, cras.Innovative proteomics for the discovery of systemically accessible cancer biomarkers suitable for imaging and targeted therapiesTargeting deeper the human serum fucome by a liquid-phase multicolumn platform in combination with combinatorial peptide ligand librariesProteomic analysis of mare follicular fluid during late follicle development.Potential predictive plasma biomarkers for cervical cancer by 2D-DIGE proteomics and Ingenuity Pathway Analysis.
P2860
Q21296806-44AF0926-A54E-48E3-B5AA-FD699C61A2ABQ28083354-E89D86B6-F02C-46C3-ADC0-F9D9539B6111Q28287384-A3E85D20-31A5-4F01-98F7-36AF1049EED4Q28478305-1B46A8C7-4FAE-4BE8-8D43-1D7995C3CEC8Q28488743-96541D6A-AE0B-45E0-B868-170CEDE91CD7Q28650185-4A79E25A-1D6F-4A08-A042-09FB87DF54A1Q28741177-74ECAD16-4753-4C79-A7B6-AE2C8F54FDCEQ30487094-94DAF896-101E-4B3E-971D-BA95C53E4DEFQ30992797-FFC168B9-F18B-4174-BE49-93595E623943Q31039257-5870E548-A1BF-4B18-AF83-02B4B6967929Q33269937-D4ED6F86-2DAD-448F-B218-AA74A25B728CQ33292219-DA9FD00C-71C8-4FB0-8D26-2EC2AB6FACD6Q33321675-535D2A5C-2CCF-4266-A290-A92CF7A4AF60Q33350452-1B9577E5-E857-4B9A-92C8-1EFF28888F6EQ33514848-77C6649D-661C-4289-AE78-FB6D0CD2A737Q33520447-A9922B9D-A930-425C-8539-497CFFF60BAFQ33525762-95AD3527-8EA2-44C9-94F7-635A1BE6F5F9Q33600047-F4BF9DB1-3818-4A21-A0C1-807E24BB3155Q33622749-D5ECF1EE-D8BF-4B06-BAF8-1A4790C27C20Q33642475-1751B677-88CA-458B-BC1B-46010A9255A3Q33665334-B75BBACD-491E-4550-829E-08EA6F12066CQ33683860-6CDC1E4E-BC76-4430-935A-E761EE0B6A7DQ33766059-722D047C-5F76-4588-9715-55882CD14E6EQ33797033-0C300FD4-E2A9-45EE-920D-58131B9AF469Q33834433-4A3ED9C8-566D-42D2-9A77-976E0821353BQ33846537-9C19B313-09A8-4B12-984F-4E5A9C50365CQ33863900-7A566BA5-BFBE-4509-B7DD-502E7243CFBAQ33872613-7D2BC575-E2FD-4B61-8E2A-74A0DD925091Q33896197-C25EB16D-F3EA-4219-9B44-85D13097304EQ33942198-FD92A9FD-5A4E-4984-B8F2-44A94873ACC2Q34022213-48EEE2E5-C977-49CE-8806-72068A502A82Q34184767-016E8DD5-F851-49C3-9149-48C1B05AAB40Q34320256-5965A477-A39D-454B-953D-C8287407E343Q34424875-6A19374C-3FD3-4D69-8B06-3726C327CDBBQ34507490-CA022341-D08A-42A2-8DB9-BCB044687B56Q34589280-C37A00AF-C589-440C-9EA3-CE5A33E47E75Q34756337-B35D459C-A167-4B19-AB0A-2450436BD4CEQ35099131-190ECCCF-2C3C-4749-94BB-8A2851DAF942Q35289839-2D7B23FB-66C6-4132-A96A-F2256BA67A1AQ35452689-A6CFD43D-9296-4845-85A1-31F417A6B9F2
P2860
Protein Equalizer Technology : the quest for a "democratic proteome".
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Protein Equalizer Technology : the quest for a "democratic proteome".
@ast
Protein Equalizer Technology : the quest for a "democratic proteome".
@en
type
label
Protein Equalizer Technology : the quest for a "democratic proteome".
@ast
Protein Equalizer Technology : the quest for a "democratic proteome".
@en
prefLabel
Protein Equalizer Technology : the quest for a "democratic proteome".
@ast
Protein Equalizer Technology : the quest for a "democratic proteome".
@en
P2093
P356
P1433
P1476
Protein Equalizer Technology : the quest for a "democratic proteome".
@en
P2093
Attilio Citterio
Egisto Boschetti
P304
P356
10.1002/PMIC.200500904
P577
2006-07-01T00:00:00Z